The 4 analysts offering 12-month price forecasts for Bio Rad Laboratories Inc have a median target of 445.00, with a high estimate of 450.00 and a low estimate of 435.00. The median estimate represents a +26.41% increase from the last price of 352.02.
The current consensus among 4 polled investment analysts is to Buy stock in Bio Rad Laboratories Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.82
Reporting Date May 12
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.